Swiss National Bank’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-32,600
Closed -$1.17M 2711
2022
Q4
$1.17M Buy
32,600
+800
+3% +$20K ﹤0.01% 2262
2022
Q3
$479K Hold
31,800
﹤0.01% 2583
2022
Q2
$426K Buy
31,800
+4,000
+14% +$63.5K ﹤0.01% 2650
2022
Q1
$536K Buy
27,800
+2,000
+8% +$41.5K ﹤0.01% 2589
2021
Q4
$612K Buy
+25,800
New +$598K ﹤0.01% 2624

Swiss National Bank's IMGO Position: Q1 2023 in Review

Swiss National Bank sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 32,600 shares — an estimated $1.17M sold.

Swiss National Bank first reported a position in IMGO in Q4 2021 and held it in 5 quarters. The position peaked at $1.17M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

  • Swiss National Bank reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
  • Swiss National Bank sold 32,600 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $1.17M.
  • Swiss National Bank first reported a position in Imago BioSciences, Inc. Common stock in Q4 2021 and held it in 5 quarters.
  • Swiss National Bank's Imago BioSciences, Inc. Common stock position peaked at $1.17M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Swiss National Bank's 13F filing for Q1 2023, filed 10 May 2023.